Literature DB >> 1356430

Central non-opioid physiological and pathophysiological effects of dynorphin A and related peptides.

V K Shukla1, S Lemaire.   

Abstract

Dynorphin A (Dyn A) and related opioid peptides derived from prodynorphin possess a high affinity for kappa opioid receptors, but they also bind to other opioid receptors (mu and delta) as well as to some non-opioid receptor sites. Although the physiological role of these peptides is not well established, recent experimental data pinpoint their particular involvement in physiological and pathophysiological conditions that relate to algesia, spinal cord injury and epilepsy. In this paper, we review data which support the concept that the non-opioid behavioral effects of Dyn A and related endogenous peptides which are observed under these conditions are physiologically and pathophysiologically relevant.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356430      PMCID: PMC1188423     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  132 in total

Review 1.  Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters.

Authors:  B Meldrum
Journal:  Clin Sci (Lond)       Date:  1985-02       Impact factor: 6.124

2.  Antinociception and paralysis induced by intrathecal dynorphin A.

Authors:  B H Herman; A Goldstein
Journal:  J Pharmacol Exp Ther       Date:  1985-01       Impact factor: 4.030

3.  Structure-function relationships in the inhibition of synaptosomal dopamine uptake by phencyclidine and analogues: potential correlation with binding site identified with [3H]phencyclidine.

Authors:  J Vignon; M Lazdunski
Journal:  Biochem Pharmacol       Date:  1984-02-15       Impact factor: 5.858

4.  [3H]MK801 binding to the NMDA receptor/ionophore complex is regulated by divalent cations: evidence for multiple regulatory sites.

Authors:  I J Reynolds; R J Miller
Journal:  Eur J Pharmacol       Date:  1988-06-22       Impact factor: 4.432

5.  A potential role for excitotoxins in the pathophysiology of spinal cord injury.

Authors:  A I Faden; R P Simon
Journal:  Ann Neurol       Date:  1988-06       Impact factor: 10.422

6.  Dynorphin1-13: interaction with other opiate ligand bindings in vitro.

Authors:  J Garzón; P Sánchez-Blázquez; J Gerhart; H H Loh; N M Lee
Journal:  Brain Res       Date:  1984-06-08       Impact factor: 3.252

7.  Site-directed alkylation of multiple opioid receptors. I. Binding selectivity.

Authors:  I F James; A Goldstein
Journal:  Mol Pharmacol       Date:  1984-05       Impact factor: 4.436

8.  Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones.

Authors:  M L Mayer; G L Westbrook; P B Guthrie
Journal:  Nature       Date:  1984 May 17-23       Impact factor: 49.962

9.  Evidence implicating substantia nigra in regulation of kindled seizure threshold.

Authors:  J O McNamara; M T Galloway; L C Rigsbee; C Shin
Journal:  J Neurosci       Date:  1984-09       Impact factor: 6.167

10.  The effect of various opiate receptor agonists on the seizure threshold in the rat. Is dynorphin an endogenous anticonvulsant?

Authors:  B Przewłocka; L Stala; W Lasoń; R Przewłocki
Journal:  Life Sci       Date:  1983       Impact factor: 5.037

View more
  2 in total

Review 1.  Pathobiology of dynorphins in trauma and disease.

Authors:  Kurt F Hauser; Jane V Aldrich; Kevin J Anderson; Georgy Bakalkin; MacDonald J Christie; Edward D Hall; Pamela E Knapp; Stephen W Scheff; Indrapal N Singh; Bryce Vissel; Amina S Woods; Tatiana Yakovleva; Toni S Shippenberg
Journal:  Front Biosci       Date:  2005-01-01

2.  Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons.

Authors:  K F Hauser; J K Foldes; C S Turbek
Journal:  Exp Neurol       Date:  1999-12       Impact factor: 5.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.